Oliver Franklin
Directeur/Membre du Conseil chez JIN MEDICAL INTERNATIONAL LTD.
Profil
Oliver Franklin is currently a Director at The Philadelphia Foundation, Dynamis Pharmaceuticals, Inc., and International House of Philadelphia.
He is also an Independent Director at Jin Medical International Ltd.
starting in 2023.
In the past, he was a Director at Dynamis Therapeutics, Inc. and a Deputy City Representative at the City of Philadelphia.
Postes actifs de Oliver Franklin
| Sociétés | Poste | Début |
|---|---|---|
| JIN MEDICAL INTERNATIONAL LTD. | Directeur/Membre du Conseil | 01/04/2023 |
| International House of Philadelphia | Corporate Officer/Principal | 25/01/2010 |
Dynamis Pharmaceuticals, Inc.
 Dynamis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. It develops drugs diabetic complications and other autoimmune diseases. The company is headquartered in Jenkintown, PA. | Directeur/Membre du Conseil | - |
The Philadelphia Foundation
 The Philadelphia Foundation Investment ManagersFinance The Philadelphia Foundation provides asset development and donor services. The company was founded by William Purves Gest on December 20, 1918 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Oliver Franklin
| Sociétés | Poste | Fin |
|---|---|---|
| City of Philadelphia (Pennsylvania) | Corporate Officer/Principal | - |
Dynamis Therapeutics, Inc.
 Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JIN MEDICAL INTERNATIONAL LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Dynamis Therapeutics, Inc.
Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA. | Health Technology |
| City of Philadelphia (Pennsylvania) | Government |
| International House of Philadelphia | |
Dynamis Pharmaceuticals, Inc.
Dynamis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. It develops drugs diabetic complications and other autoimmune diseases. The company is headquartered in Jenkintown, PA. | Health Technology |
The Philadelphia Foundation
The Philadelphia Foundation Investment ManagersFinance The Philadelphia Foundation provides asset development and donor services. The company was founded by William Purves Gest on December 20, 1918 and is headquartered in Philadelphia, PA. | Finance |
